Seema Dawood: Acquired Platelet Dysfunction with Eosinophilia – Bleeding Despite Normal Platelet Count
Seema Dawood, Medical Laboratory Technologist at The Aga Khan University Hospital, shared a post on LinkedIn:
“Acquired Platelet Dysfunction with Eosinophilia (APDE)
Condition characterized by bleeding tendency due to abnormal Platelet function, despite having a normal or near-normal platelet count, occurring together with Eosinophilia (increased Eosinophils in the blood).
Key Features
Patients present with abnormal bleeding: purpura, epistaxis, gum bleeding, etc.
Platelet count is usually normal, but platelet function is impaired.
Eosinophilia is present, commonly associated with:
- Parasitic infections
- Allergic diseases
- Certain immune-mediated conditions
Pathophysiology
Eosinophils release toxic granule proteins (e.g., Major Basic Protein, Eosinophil Cationic Protein).
These substances interfere with platelet function (aggregation and adhesion).
Result: ineffective hemostasis despite normal platelet count.
Clinical Importance
- Patients may have bleeding tendency even though platelet count is normal.
- Reported frequently in regions with high prevalence of parasitic infections (e.g., Southeast Asia).
- Treatment focuses on managing the underlying cause of Eosinophilia (e.g., treating parasitic infections).
- Once eosinophil count decreases, platelet function usually improves.
Summary:
APDE is an acquired condition where platelet dysfunction occurs in association with Eosinophilia, leading to bleeding tendency despite normal platelet count.
It is often linked to parasitic infections or allergies and improves when Eosinophilia is treated.
APDE is the only disease in which Pale Platelets are found.
Therefore, before reporting Pale Platelets, it is important to consider other consistent findings such as marked eosinophilia and the presence of purpura in the patient.”

See more in the gallery.
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda